Lower-Limb Rehabilitation Robot Training for Sarcopenia
Research on Lower Limb Rehabilitation Robots for Sarcopenia
1 other identifier
interventional
40
1 country
1
Brief Summary
The goal of this clinical trial is to learn whether lower-limb rehabilitation robot training combined with nutrition education can improve muscle mass and physical function in adults aged 60 years or older with sarcopenia. The main questions it aims to answer are:
- 1.Does lower-limb rehabilitation robot training improve muscle mass and body composition?
- 2.Does the training improve muscle strength, walking ability, balance, and physical function?
- 3.Complete assessments before the intervention, around week 5, and after week 8.
- 4.Receive either 8 weeks of lower-limb rehabilitation robot training using the MRG-P110 plus nutrition education, or usual care including exercise and nutrition education.
- 5.Complete assessments of body composition, muscle strength, walking ability, balance, and health-related quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 9, 2026
CompletedFirst Submitted
Initial submission to the registry
September 15, 2026
CompletedFirst Posted
Study publicly available on registry
September 21, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2027
September 21, 2026
September 1, 2026
9 months
September 15, 2026
September 15, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Skeletal Muscle Mass Index (SMI)
Skeletal muscle mass index (SMI) will be measured in kg/m². Lower values indicate lower skeletal muscle mass. According to the criteria used in this study, low muscle mass is defined as SMI ≤7.0 kg/m² in men and ≤5.7 kg/m² in women.
Baseline, Week 5, and Week 8
Handgrip Strength
Handgrip strength of the dominant hand will be measured in kilograms (kg). Higher values indicate greater muscle strength. According to the criteria used in this study, low muscle strength is defined as \<28 kg in men and \<18 kg in women.
Baseline, Week 5, and Week 8
4-Meter Gait Speed
Gait speed will be assessed using the 4-meter walk test and reported in meters per second (m/s). Higher values indicate better walking performance. According to the criteria used in this study, a gait speed \<1.0 m/s indicates impaired physical performance.
Baseline, Week 5, and Week 8
Secondary Outcomes (7)
Five-Time Sit-to-Stand Test
Baseline, Week 5, and Week 8
Functional Ambulation Category
Baseline, Week 5, and Week 8
Short Physical Performance Battery
Baseline, Week 5, and Week 8
EQ-5D Health-Related Quality of Life
Baseline, Week 5, and Week 8
Lower Extremity Functional Scale (LEFS)
Baseline, Week 5, and Week 8
- +2 more secondary outcomes
Study Arms (2)
Robot-Assisted Training Group
EXPERIMENTALParticipants will receive lower-limb rehabilitation robot training using the MRG-P110 for 8 weeks, three sessions per week, 30 minutes per session, for a total of 24 sessions. Nutrition education will be provided after each training session.
Usual Care Group
ACTIVE COMPARATORParticipants will receive usual care, including exercise and nutrition education, without additional lower-limb rehabilitation robot training.
Interventions
Participants will receive lower-limb rehabilitation robot training using the MRG-P110 for 8 weeks, three sessions per week, 30 minutes per session, for a total of 24 sessions. Training parameters will be individualized according to participant height and baseline walking speed. Step length will initially be set at 15% of height, and walking speed at 80% of baseline walking speed. Training intensity will be monitored using the Borg Rating of Perceived Exertion scale and maintained at 5-6.
Participants will receive nutrition education as part of the study intervention.
Participants in the control group will receive usual care exercise without additional lower-limb rehabilitation robot training.
Eligibility Criteria
You may qualify if:
- Aged 60 years or older.
- Meets the diagnostic criteria for sarcopenia according to the Asian Working Group for Sarcopenia (AWGS).
- Conscious and able to understand and follow movement instructions.
- Able to stand for at least 1 minute.
- Physically able to tolerate lower-limb rehabilitation robot training.
You may not qualify if:
- Body weight greater than 135 kg.
- Height less than 145 cm or greater than 190 cm, resulting in incompatibility with the exoskeleton.
- Presence of an unhealed fracture.
- Joint contracture or excessive lower-limb muscle tone that prevents participation in robotic training.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Taipei Medical University Hospitallead
- HIWIN Technologies Corporationcollaborator
Study Sites (1)
Taipei Medical University Hospital
Taipei, Taipei City, 11031, Taiwan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
SHENG-WEN SU
CONTACT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 15, 2026
First Posted
September 21, 2026
Study Start
March 9, 2026
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
January 1, 2027
Last Updated
September 21, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will not share
Individual participant data are not planned to be shared because no data-sharing arrangement has been established for this study, and participant confidentiality will be maintained.